These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25511985)

  • 1. In vivo evaluation of mutant selection window of cefquinome against Escherichia coli in piglet tissue-cage model.
    Zhang B; Gu X; Li Y; Li X; Gu M; Zhang N; Shen X; Ding H
    BMC Vet Res; 2014 Dec; 10():297. PubMed ID: 25511985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of a clinical Escherichia coli strain to repeated cefquinome exposure in a piglet tissue-cage model.
    Gu M; Zhang N; Zhang L; Xiong M; Yang Y; Gu X; Shen X; Ding H
    BMC Vet Res; 2015 Jul; 11():169. PubMed ID: 26209108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing the mutant selection window hypothesis with Escherichia coli exposed to levofloxacin in a rabbit tissue cage infection model.
    Ni W; Song X; Cui J
    Eur J Clin Microbiol Infect Dis; 2014 Mar; 33(3):385-9. PubMed ID: 24036892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between Cefquinome PK/PD Parameters and Emergence of Resistance of Staphylococcus aureus in Rabbit Tissue-Cage Infection Model.
    Xiong M; Wu X; Ye X; Zhang L; Zeng S; Huang Z; Wu Y; Sun J; Ding H
    Front Microbiol; 2016; 7():874. PubMed ID: 27375594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the mutant selection window hypothesis with fosfomycin against Escherichia coli and Pseudomonas aeruginosa: an in vitro and in vivo comparative study.
    Pan AJ; Mei Q; Ye Y; Li HR; Liu B; Li JB
    J Antibiot (Tokyo); 2017 Feb; 70(2):166-173. PubMed ID: 27756910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mutant selection window in rabbits infected with Staphylococcus aureus.
    Cui J; Liu Y; Wang R; Tong W; Drlica K; Zhao X
    J Infect Dis; 2006 Dec; 194(11):1601-8. PubMed ID: 17083047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of four antimicrobials against Riemerella anatipestifer isolates: a comparison of minimum inhibitory concentrations and mutant prevention concentrations for ceftiofur, cefquinome, florfenicol, and tilmicosin.
    Li Y; Zhang Y; Ding H; Mei X; Liu W; Zeng J; Zeng Z
    BMC Vet Res; 2016 Nov; 12(1):250. PubMed ID: 27829415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.
    Firsov AA; Smirnova MV; Lubenko IY; Vostrov SN; Portnoy YA; Zinner SH
    J Antimicrob Chemother; 2006 Dec; 58(6):1185-92. PubMed ID: 17028094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing the mutant selection window in rabbits infected with methicillin-resistant Staphylococcus aureus exposed to vancomycin.
    Zhu YL; Hu LF; Mei Q; Cheng J; Liu YY; Ye Y; Li JB
    J Antimicrob Chemother; 2012 Nov; 67(11):2700-6. PubMed ID: 22809703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and ex vivo pharmacodynamics of cefquinome in porcine serum and tissue cage fluids.
    Zhang BX; Lu XX; Gu XY; Li XH; Gu MX; Zhang N; Shen XG; Ding HZ
    Vet J; 2014 Mar; 199(3):399-405. PubMed ID: 24423605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, bioavailability and dose assessment of Cefquinome against Escherichia coli in black swans (Cygnus atratus).
    Zhao DH; Wang XF; Wang Q; Li LD
    BMC Vet Res; 2017 Jul; 13(1):226. PubMed ID: 28754112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing the mutant selection window hypothesis in vitro and in vivo with Staphylococcus aureus exposed to fosfomycin.
    Mei Q; Ye Y; Zhu YL; Cheng J; Chang X; Liu YY; Li HR; Li JB
    Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):737-44. PubMed ID: 25424036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic/pharmacodynamic assessment of cefquinome against Actinobacillus Pleuropneumoniae in a piglet tissue cage infection model.
    Zhang L; Wu X; Huang Z; Zhang N; Wu Y; Cai Q; Shen X; Ding H
    Vet Microbiol; 2018 Jun; 219():100-106. PubMed ID: 29778180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic/pharmacodynamic integration of cefquinome against Pasteurella Multocida in a piglet tissue cage model.
    Zhang L; Wu X; Huang Z; Kang Z; Chen Y; Shen X; Cai Q; Ding H
    J Vet Pharmacol Ther; 2019 Jan; 42(1):60-66. PubMed ID: 30407642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, bioavailability and PK/PD relationship of cefquinome for Escherichia coli in Beagle dogs.
    Zhou YF; Zhao DH; Yu Y; Yang X; Shi W; Peng YB; Liu YH
    J Vet Pharmacol Ther; 2015 Dec; 38(6):543-8. PubMed ID: 25776615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enrichment of resistant Staphylococcus aureus at ciprofloxacin concentrations simulated within the mutant selection window: bolus versus continuous infusion.
    Firsov AA; Smirnova MV; Strukova EN; Vostrov SN; Portnoy YA; Zinner SH
    Int J Antimicrob Agents; 2008 Dec; 32(6):488-93. PubMed ID: 18790614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant prevention concentrations of pradofloxacin for susceptible and mutant strains of Escherichia coli with reduced fluoroquinolone susceptibility.
    Marcusson LL; Komp Lindgren P; Olofsson SK; Hughes D; Cars O
    Int J Antimicrob Agents; 2014 Oct; 44(4):354-7. PubMed ID: 25129317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of bacterial resistance using in vitro dynamic models: area under the concentration-time curve related to either the minimum inhibitory or mutant prevention antibiotic concentration.
    Strukova EN; Portnoy YA; Zinner SH; Firsov AA
    J Antimicrob Chemother; 2016 Mar; 71(3):678-84. PubMed ID: 26626718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of resistant Streptococcus pneumoniae in an in vitro dynamic model that simulates moxifloxacin concentrations inside and outside the mutant selection window: related changes in susceptibility, resistance frequency and bacterial killing.
    Zinner SH; Lubenko IY; Gilbert D; Simmons K; Zhao X; Drlica K; Firsov AA
    J Antimicrob Chemother; 2003 Oct; 52(4):616-22. PubMed ID: 12951352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration.
    Olofsson SK; Marcusson LL; Komp Lindgren P; Hughes D; Cars O
    J Antimicrob Chemother; 2006 Jun; 57(6):1116-21. PubMed ID: 16624874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.